Feimeng Zheng

5PUBLICATIONS
0CO-AUTHORS
Molecular targetsCancer cell biologyHaematological tumoursAvionics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 17, 2023
ACADL suppresses PD-L1 expression to prevent cancer immune evasion by targeting Hippo/YAP signaling in lung adenocarcinoma.

Li Li, Ling-Ling Wang, Tao-Li Wang

|Oct 12, 2022
NDR1 activates CD47 transcription by increasing protein stability and nuclear location of ASCL1 to enhance cancer stem cell properties and evasion of phagocytosis in small cell lung cancer.

Ling-Ling Wang, Xiao-Yun Wan, Tao-Li Wang

|May 05, 2022
NDR1 increases NOTCH1 signaling activity by impairing Fbw7 mediated NICD degradation to enhance breast cancer stem cell properties.

Ling-Ling Wang, Xiao-Yun Wan, Chun-Qi Liu

|Jun 08, 2019
β-Asarone increases doxorubicin sensitivity by suppressing NF-κB signaling and abolishes doxorubicin-induced enrichment of stem-like population by destabilizing Bmi1.

Li-Na Lv, Xiao-Chao Wang, Li-Ju Tao

|Jan 20, 2016
Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype.

Feimeng Zheng, Caifeng Yue, Guohui Li

Pageof 1

Frequent Collaborators